Main Content
CV of Prof. Dr. Markus A. Ruegg
ORCID | 0000-0002-4974-9384 | |
Nationality: | Swiss | |
Positions: | Since 2021 – | Co-founder and CEO of SEAL Therapeutics Ltd. See: www.sealtherapeutics.com |
Since 2004 – | Full Professor of Neurobiology | |
1998 – 2004 | Associate Professor of Neurobiology | |
1992 – 1997 | Assistant Professor | |
1989 – 1992 | Postdoctoral Fellow, Department of Neurobiology, Stanford University School of Medicine | |
Education: | 1985 – 1988 | Graduate Studies in Biochemistry and Neurobiology, Institute of Biochemistry University of Zurich |
1979 – 1985 | Studies of Biochemistry at the University of Zurich | |
1975 – 1979 | Kantonsschule Aarau, Aarau, Switzerland, Matura Typus B | |
Selected Awards & Honors: | 2021 | Lelio Orci Award from Life Sciences Switzerland |
2000 | Robert Bing Prize from the Swiss Academy of Medical Sciences | |
1989 | Faculty of Sciences of the University of Zürich: Distinction for Ph.D. thesis | |
Selected Memberships: | Since 2021 – | Vice-President of the Swiss Foundation for Research and Muscle Diseases (FSRMM) |
Since 2021 – | President of the Animal Ethics Commission of the Kantons of Basel-Stadt, Basel-Landschaft and Aargau. | |
Since 2020 – | Co-Editor in Chief Skeletal Muscle | |
Since 2020 – | Editorial Board of “Current Research in Physiology” | |
Since 2017 – | Section head of Musculoskeletal Pharmacology of “Faculty1000Prime” | |
Since 2017 – | Editorial Board of “Current Opinion in Physiology” | |
Since 2014 – | Associate Editor of "Journal of Neuromuscular Diseases" | |
2014 – 2020 | Member of the ENMC research committee | |
Since 2013 – | Chairman of the Scientific Advisory Committee of the Swiss Foundation for Research and Muscle Diseases (FSRMM) | |
2012 – 2018 | Member of the Medical Research Committee of “Muscular Dystrophy Campaign” UK | |
Since 2009 – | Scientific and Medical Advisory Board of "Cure CMD" | |
2000 – 2007 | Council member of the Swiss Society for Neuroscience |